abstract |
Provided herein are 2,5-disubstituted arylsulfonamides that are useful for modulating CCR3 activity, and pharmaceutical compositions thereof. Also provided herein are the methods of its use to treat, prevent or ameliorate one or more symptoms of a disease disorder or condition mediated by CCR3. |